Company Directory

Kala Bio develops a pipeline of ocular products using its MPP technology which enhances penetration through the tear film mucus. Beyond ophthalmology, it has potential applications include women’s reproductive health, respiratory and gastrointestinal diseases.

Kaléo is a drug-delivery device company, providing innovation in the field of autoinjector technology. Kaléo’s Aerio™ platform powers its portfolio of autoinjector products, as well as products under development for third parties.

Kedalion Therapeutics, acquired by Novartis in 2022, was a clinical-stage ophthalmic drug delivery company developing the AcuStream technology. The device's horizontal stream delivers topical ocular drugs precisely and accurately, aiming to reduce required dose compared with standard drops.

Keldmann Healthcare is a family-owned drug delivery system innovation and business development consultancy. The company is experienced with various drug delivery routes and offers its services as a team member or lead in client projects.

KERN LIEBERS manufactures high-precision springs, stamped parts and assemblies for demanding medical applications, including customised components for drug delivery devices such as self-administration systems for insulin and other injectables, and for inhalers.

Kestrel Technology Consulting works with its clients and partners on innovative technology and product development projects in numerous industrial sectors including medical (drug delivery, surgical, home healthcare, ophthalmic, biotechnology) and sustainable design and manufacture.

Key Tech designs and develops medical, industrial and consumer products using novel sensors, wireless, ultrasound, microfluidics, optics and robotics. Its experience within drug delivery includes with injection devices and connectivity. It has an interdisciplinary team of  scientists, engineers and designers.

Keylika is developing the world’s first resorbable buccal patch (Rx) for iron administration to treat IDA, especially in women of childbearing age suffering from moderate-to-severe ID, as a potential best-in-class breakthrough therapy.

Kindeva is a CDMO offering its partners integrated, end-to-end capabilities spanning formulation, product development, scale-up manufacturing and commercial manufacturing. Its full-service innovation offering covers injectables, inhalation, transdermal delivery, and intradermal delivery (microneedles).